These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 1610613

  • 1. [Expansion of infarction, dilatation and ventricular remodelling. Therapeutic potential of angiotensin-converting enzyme inhibitors].
    de Sá ME.
    Rev Port Cardiol; 1992 Mar; 11(3):267-72. PubMed ID: 1610613
    [Abstract] [Full Text] [Related]

  • 2. [Left ventricular remodeling after myocardial infarction].
    Anguenot T, Bassand JP, Bernard Y, Schiele F.
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):781-7. PubMed ID: 1530420
    [Abstract] [Full Text] [Related]

  • 3. [Physiopathology of left ventricular remodeling after myocardial infarction].
    Bassand JP, Anguenot T.
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():43-9. PubMed ID: 1838920
    [Abstract] [Full Text] [Related]

  • 4. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [Abstract] [Full Text] [Related]

  • 5. [Ventricular "remodeling" after myocardial infarction].
    Cohen-Solal A, Himbert D, Guéret P, Gourgon R.
    Arch Mal Coeur Vaiss; 1991 Jun; 84(6):847-53. PubMed ID: 1910327
    [Abstract] [Full Text] [Related]

  • 6. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R, Perindopril and Remodeling in Elderly with Acute Myocardial Infarction Investigators.
    Arch Intern Med; 2006 Mar 27; 166(6):659-66. PubMed ID: 16567606
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M, Nakamura Y, Omura T, Izumi Y, Matsumoto R, Oda S, Takeuchi K, Kim S, Iwao H, Yoshikawa J.
    Heart; 2005 Aug 27; 91(8):1080-5. PubMed ID: 16020603
    [Abstract] [Full Text] [Related]

  • 8. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R, Papa K, Bernocchi P, Gimbatti OJ, Golcea SS, Bettini A, Ceconi C.
    Ital Heart J; 2005 Nov 27; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [Abstract] [Full Text] [Related]

  • 9. Prevention of post-infarction left ventricular remodeling by ACE-inhibitors.
    St John Sutton M, Pfeffer MA.
    Cardiologia; 1994 Dec 27; 39(12 Suppl 1):27-30. PubMed ID: 7634281
    [Abstract] [Full Text] [Related]

  • 10. [Converting enzyme inhibitors and coronary failure].
    Castaigne A, Saal JP, Albo C, Verschuren P, Pham I.
    Rev Prat; 1992 Dec 15; 42(20):2568-73. PubMed ID: 1299942
    [Abstract] [Full Text] [Related]

  • 11. [Remodeling of the left ventricle after myocardial infarction].
    Droździak E, Piwowarska W.
    Pol Merkur Lekarski; 1996 Oct 15; 1(4):219-22. PubMed ID: 9156927
    [Abstract] [Full Text] [Related]

  • 12. What have the ACE-inhibitor trials in postmyocardial patients with left ventricular dysfunction taught us?
    Reynolds G, Hall AS, Ball SG.
    Eur J Clin Pharmacol; 1996 Oct 15; 49 Suppl 1():S35-9. PubMed ID: 8834930
    [Abstract] [Full Text] [Related]

  • 13. [Indications for ACE inhibitors in the postinfarct period].
    Ertl G, Gaudron P, Neubauer S, Hu K, Zdrojewski T, Horn M, Kochsiek K.
    Z Kardiol; 1994 Oct 15; 83 Suppl 4():65-74. PubMed ID: 7856283
    [Abstract] [Full Text] [Related]

  • 14. [Remodeling of the left ventricle following myocardial infarction: physiopathology and prevention].
    Lerch R, Ricou F.
    Schweiz Med Wochenschr; 1994 Sep 03; 124(35):1538-44. PubMed ID: 7939520
    [Abstract] [Full Text] [Related]

  • 15. [Remodeling with angiotensin-converting enzyme inhibitors: from GISSI to PREAMI].
    Nicolosi GL.
    Ital Heart J; 2005 Nov 03; 6 Suppl 7():33S-39S. PubMed ID: 16485515
    [Abstract] [Full Text] [Related]

  • 16. Ventricular remodeling following myocardial infarction: a description of the pathologic process, current investigation, and suggested therapy.
    Fara AM.
    Crit Care Nurs Clin North Am; 1992 Jun 03; 4(2):325-37. PubMed ID: 1599655
    [Abstract] [Full Text] [Related]

  • 17. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials.
    Greenberg BH.
    J Card Fail; 2002 Dec 03; 8(6 Suppl):S486-90. PubMed ID: 12555162
    [Abstract] [Full Text] [Related]

  • 18. [Prevention of post-infarction remodelling with L-carnitine: multicenter study CEDIM (L-Carnitine digital echocardiography myocardial infarction)].
    Rizzon P, Iliceto S.
    Cardiologia; 1994 Dec 03; 39(12 Suppl 1):31-5. PubMed ID: 7634289
    [Abstract] [Full Text] [Related]

  • 19. Cardiac remodeling and failure after myocardial infarction.
    Nicolosi GL.
    J Cardiovasc Risk; 1994 Dec 03; 1(4):310-3. PubMed ID: 7621314
    [Abstract] [Full Text] [Related]

  • 20. Ventricular remodeling and its prevention in the treatment of heart failure.
    Patten RD, Udelson JE, Konstam MA.
    Curr Opin Cardiol; 1998 May 03; 13(3):162-7. PubMed ID: 9649938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.